IXICO works across many rare neurological diseases and can develop, optimise and apply advanced imaging and analytical techniques to produce disease-focused imaging endpoints.
Example indications include: Spinocerebellar Ataxia (SCA), Friedreich's Ataxia (FA), Amyotrophic Lateral Sclerosis (ALS), and Cerebral Amyloid Angiopathy (CAA). In addition, the IXI™ platform's analysis pipelines can also be optimised for paediatric populations.